![Ofir Moreno](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Ofir Moreno worked as a Senior Director-Chemistry at Dendreon Corp.
from 2003 to 2007.
He then worked at MEI Pharma, Inc. from 2010 to 2022, where he held the position of Senior Vice President-Pharmaceutical Sciences from 2019 to 2022.
Moreno holds a doctorate degree from Harvard University and an undergraduate degree from Cornell University.
Eerdere bekende functies van Ofir Moreno
| Bedrijven | Functie | Einde |
|---|---|---|
| LITE STRATEGY, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2019 |
| DENDREON CORPORATION | Corporate Officer/Principal | 01-11-2007 |
Opleiding van Ofir Moreno
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
31
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MEI Pharma, Inc.
 MEI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies MarketScreener 
